Literature DB >> 27790819

Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.

Mattia Arrigo1,2, Etienne Gayat1, Jiri Parenica3, Shiro Ishihara4, Jian Zhang5, Dong-Ju Choi6, Jin Joo Park6, Khalid F Alhabib7, Naoki Sato4, Oscar Miro8, Aldo P Maggioni9, Yuhui Zhang5, Jindrich Spinar3, Alain Cohen-Solal10, Theodore J Iwashyna11, Alexandre Mebazaa1.   

Abstract

AIMS: Several clinical conditions may precipitate acute heart failure (AHF) and influence clinical outcome. In this study we hypothesized that precipitating factors are independently associated with 90-day risk of death in AHF. METHODS AND
RESULTS: The study population consisted of 15 828 AHF patients from Europe and Asia. The primary outcome was 90-day all-cause mortality according to identified precipitating factors of AHF [acute coronary syndrome (ACS), infection, atrial fibrillation (AF), hypertension, and non-compliance]. Mortality at 90 days was 15.8%. AHF precipitated by ACS or by infection showed increased 90-day risk of death compared with AHF without identified precipitants [hazard ratio (HR) 1.69, 95% confidence interval (CI) 1.44-1.97, P < 0.001; and HR 1.51, 95% CI 1.18-1.92, P = 0.001), while AHF precipitated by AF showed lower 90-day risk of death (HR 0.56, 95% CI 0.42-0.75, P < 0.001), after multivariable adjustment. The risk of death in AHF precipitated by ACS was the highest during the first week after admission, while in AHF precipitated by infection the risk of death had a delayed peak at week 3. In AHF precipitated by AF, a trend toward reduced risk of death during the first weeks was shown. At weeks 5-6, AHF precipitated by ACS, infection, or AF showed similar risk of death to that of AHF without identified precipitants.
CONCLUSIONS: Precipitating factors are independently associated with 90-day mortality in AHF. AHF precipitated by ACS or infection is independently associated with higher, while AHF precipitated by AF is associated with lower 90-day risk of death.
© 2016 The Authors. European Journal of Heart Failure © 2016 European Society of Cardiology.

Entities:  

Keywords:  Acute coronary syndrome; Acute heart failure; Atrial fibrillation; Mortality; Outcome; Precipitating factor

Mesh:

Year:  2016        PMID: 27790819     DOI: 10.1002/ejhf.682

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  29 in total

1.  History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.

Authors:  Ravi B Patel; Muthiah Vaduganathan; Aruna Rikhi; Hrishikesh Chakraborty; Stephen J Greene; Adrian F Hernandez; G Michael Felker; Margaret M Redfield; Javed Butler; Sanjiv J Shah
Journal:  JACC Heart Fail       Date:  2018-11-05       Impact factor: 12.035

2.  Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications.

Authors:  Matthieu Legrand; Pierre-Olivier Ludes; Ziad Massy; Patrick Rossignol; Jiri Parenica; Jin-Joo Park; Shiro Ishihara; Khalid F AlHabib; Aldo Maggioni; Òscar Miró; Naoki Sato; Alain Cohen-Solal; Enrique Fairman; Johan Lassus; Veli-Pekka Harjola; Christian Mueller; Franck W Peacock; Dong-Ju Choi; Patrick Plaisance; Jindřich Spinar; Mikhail Kosiborod; Alexandre Mebazaa; Etienne Gayat
Journal:  Clin Res Cardiol       Date:  2017-10-28       Impact factor: 5.460

3.  Precipitating Factors for Hospitalization with Heart Failure: Prevalence and Clinical Impact Observations from the Gulf CARE (Gulf aCute heArt failuRe rEgistry).

Authors:  Amar M Salam; Kadhim Sulaiman; Alawi A Alsheikh-Ali; Rajvir Singh; Khalid F AlHabib; Ibrahim Al-Zakwani; Nidal Asaad; Awad Al-Qahtani; Mohammed Al-Jarallah; Wael AlMahmeed; Bassam Bulbanat; Mustafa Ridha; Nooshin Bazargani; Haitham Amin; Ahmed Al-Motarreb; Prashanth Panduranga; Husam AlFaleh; Abdulla Shehab; Jassim Al Suwaidi
Journal:  Med Princ Pract       Date:  2019-09-16       Impact factor: 1.927

4.  Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study.

Authors:  Òscar Miró; Koji Takagi; Étienne Gayat; Víctor Gil; Pere Llorens; Francisco J Martín-Sánchez; Javier Jacob; Pablo Herrero-Puente; Rosa Escoda; María Pilar López-Díez; Amparo Valero; Marta Fuentes; José M Garrido; Eva Salvo; Miguel A Rizzi; Alfons Aguirre; Lissete Travería Bécquer; Alberto Domínguez-Rodríguez; Joan Padrosa; Gemma Martínez; Mattia Arrigo; Yonathan Freund; Alexandre Mebazaa
Journal:  Clin Res Cardiol       Date:  2019-04-29       Impact factor: 5.460

5.  Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.

Authors:  Elke Platz; Pardeep S Jhund; Brian L Claggett; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Salim Yusuf; Scott D Solomon; John J McMurray
Journal:  Eur J Heart Fail       Date:  2017-09-04       Impact factor: 15.534

Review 6.  Blood Pressure Reduction in Hypertensive Acute Heart Failure.

Authors:  Nicholas Harrison; Peter Pang; Sean Collins; Phillip Levy
Journal:  Curr Hypertens Rep       Date:  2021-02-20       Impact factor: 5.369

Review 7.  Optimising Heart Failure Therapies in the Acute Setting.

Authors:  Mattia Arrigo; Petra Nijst; Alain Rudiger
Journal:  Card Fail Rev       Date:  2018-05

Review 8.  Ultrafiltration for acute heart failure.

Authors:  Mehul Srivastava; Nicholas Harrison; Ana Francisca Sma Caetano; Audrey R Tan; Mandy Law
Journal:  Cochrane Database Syst Rev       Date:  2022-01-21

Review 9.  Acute heart failure.

Authors:  Mattia Arrigo; Mariell Jessup; Wilfried Mullens; Nosheen Reza; Ajay M Shah; Karen Sliwa; Alexandre Mebazaa
Journal:  Nat Rev Dis Primers       Date:  2020-03-05       Impact factor: 52.329

10.  Readmission and mortality among heart failure patients with history of hypertension in a statewide database.

Authors:  Michail Giakoumis; Davit Sargsyan; John B Kostis; Javier Cabrera; Sanketkumar Dalwadi; William J Kostis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.